Common clinical indications

• Prevention and treatment of venous thromboembolic events (VTE) in pediatric patients from birth (≥37 weeks gestation and ≥2.6 kg) to <18 years, following at least 5 days of initial parenteral anticoagulation.
• Prevention and treatment of VTE in adults.
• Thromboprophylaxis following the Fontan procedure in pediatric patients ≥2 years to <18 years.

Frequently asked questions

What is Rivaroxaban used for?

Rivaroxaban (Rivaroxaban) is listed in YMed Atlas under Anticoagulant, factor Xa inhibitor. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.

How do I adjust dosing for renal impairment or special populations?

Review the dosing sections and references for this monograph. Many agents require renal or hepatic adjustment; pediatric, pregnancy, and lactation considerations are clinician-specific. This interface is educational and does not replace individualized prescribing decisions.

Is this medical advice?

No. YMed Atlas drug pages support learning and quick reference. They are not a substitute for clinical judgment, pharmacist review, or formal interaction checking with a complete medication list.